Antimicrobial Resistance in the 21st Century. (2018)

• Record Type: Book
• Further Information: Note: I.W. Fong, David Shalaes, Karl Drlica, editors.
• Editors: Fong, I. W (Ignatius W.); Shlaes, David M; Drlica, Karl
• Contents: Intro; Preface; Contents; Contributors; About the Editors; Chapter 1: Introduction: Coordinated Global Action Is Needed to Combat Antimicrobial Resistance; 1.1 Evolution of Resistance; 1.2 Defining the Problem; 1.3 Moving Forward; 1.4 Concluding Thoughts; References; Part I: Examples of Resistance; Chapter 2: Antimicrobial Resistance Among Streptococcus pneumoniae; 2.1 Introduction; 2.2 Basis of Antimicrobial Resistance in Streptococcus pneumoniae; 2.2.1 Penicillin and ß-Lactam-Resistant Streptococcus pneumoniae; 2.2.2 Macrolide Resistance in Streptococcus pneumoniae 2.2.3 Fluoroquinolone Resistance in Streptococcus pneumoniae2.2.4 Resistance to Other Antibiotics; 2.2.5 Multidrug-Resistant (MDR) Streptococcus pneumoniae; 2.3 Risk Factors for Infection by Drug-Resistant Pneumococcus; 2.3.1 Risk Factors Related to Penicillin Resistance; 2.3.2 Risk Factors Related to Macrolide Resistance; 2.3.3 Risk Factors Related to Fluoroquinolone Resistance; 2.3.4 Risk Factors Related to Multidrug-Resistance; 2.4 Pneumococcal Serotypes and Antibiotic Resistance; 2.5 Global Resistance Trends; 2.6 Impact of Vaccines on Resistance 3.2.2.2 Mechanisms of Virulence3.2.2.3 Antimicrobial Susceptibility Testing; 3.2.2.4 Molecular Typing of MRSA; 3.2.2.5 Molecular Origins of MRSA; 3.2.3 Epidemiology of CA-MRSA; 3.2.3.1 Geographic Characteristics; 3.2.3.2 Age and Sex; 3.2.3.3 Race, Ethnicity, and Socioeconomic Status; 3.2.3.4 Other Epidemiologic Risk Factors for Colonization; 3.3 Considerations in Management of MRSA Infection in the Community; 3.3.1 Clinical Presentation; 3.3.2 Management of MRSA Skin or Soft Tissue Infections; 3.3.3 Management of Severe or Invasive MRSA Infections 3.3.4 Newer Developments in Antimicrobial Treatment of MRSA Infections3.3.5 Strategies to Eliminate S. aureus Colonization as Part of Treatment for Infected Patients; 3.4 Transmission and Outbreaks of MRSA in the Community; 3.4.1 Transmission of CA-MRSA; 3.4.2 Outbreaks of MRSA in the Community; 3.5 Prevention of MRSA in the Community; 3.5.1 Public Health Officials; 3.5.2 Medical Providers and Infection Control Practitioners; 3.5.3 Patients and Members of the Community; 3.6 Future Directions; 3.6.1 Vancomycin Resistance; 3.6.2 Vaccine and Other Novel Prevention/Treatment Approaches
• Edition: Second edition
• Publisher Details: Cham : Springer
• Publication Date: 2018
• Extent: 1 online resource
• Subjects: 616.9041; Medicine; Anti-infective agents; Drug resistance in microorganisms; Communicable diseases -- Forecasting; Immunology; Emerging infectious diseases; Microbiology; Medical virology; Epidemiology; HEALTH & FITNESS / Diseases / General; MEDICAL / Clinical Medicine; MEDICAL / Diseases; MEDICAL / Evidence-Based Medicine; MEDICAL / Internal Medicine; Medical -- Infectious Diseases; Science -- Life Sciences -- Biology -- Microbiology; Medical -- Microbiology; Medical -- Epidemiology; Medical -- Public Health; Infectious & contagious diseases; Microbiology (non-medical); Medical microbiology & virology; Epidemiology & medical statistics; Public health & preventive medicine; Medical -- Immunology; Immunology; Electronic books
• Languages: English
• ISBNs: 9783319785387; 3319785389
• Related ISBNs: 9783319785370
• Notes: Note: Includes bibliographical references and index.; Note: Online resource; title from PDF file page (EBSCO, viewed November 14, 2018).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.